GGrantIndex
Sort

53,477 grants matching addiction

Preventing School Exclusion and Opioid Misuse: Effectiveness of the Inclusive Skill-building Learning Approach (ISLA)

$728,158
Rhonda Nese · University Of Oregon · R01 · FY2025 · DA

Emergency Department-Initiated Medications for Alcohol Use Disorder

$728,102
Kathryn Hawk · Yale University · R01 · FY2025 · AA

Promoting alcohol treatment engagement post-hospitalization with brief intervention, medications, and CBT4CBT: A randomized clinical trial in a diverse patient population

$727,945
E. Jennifer Edelman · Yale University · R01 · FY2022 · AA

Low Nicotine Content Cigarettes in Vulnerable Populations: Opioid Abusers

$727,889
Stacey C Sigmon · University Of Vermont & St Agric College · U54 · FY2018 · DA

A Clinical Laboratory with Integrated Neuroscience (CLIN) for Early Evaluation of Medications for Substance Use Disorders

$727,881
Kyle Matthew Kampman · University Of Pennsylvania · UG1 · FY2022 · DA

Smoking Cessation Self-Help for Dual Users of Tobacco Cigarettes and E-Cigarettes

$727,803
Thomas H. Brandon · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2016 · DA

Modeling circuit-specific psychiatric deep brain stimulation and its cognitive effects in macaques

$727,629
Benjamin Y Hayden · University Of Minnesota · R01 · FY2021 · MH

SCH: INT: Collaborative Research: An intelligent Pervasive Augmented reaLity therapy (iPAL) for Opioid Use Disorder and Recovery

$727,615
Laura M Stanley · Montana State University · · FY2020 · CSE

Development of I-THP as New Medication for Drug Addiction (DP1)

$727,500
Jia Bei Wang · University Of Maryland Baltimore · DP1 · FY2011 · DA

Novel Nanovaccines Against Nicotine Addiction

$727,306
Chenming M Zhang · Virginia Polytechnic Inst And St Univ · U01 · FY2014 · DA

Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings

$727,222
Frederick Lewis Altice · Yale University · R01 · FY2017 · DA

Brain Endophenotypes Modulating Drug Abuse Risk

$727,118
Robert A Zucker · University Of Michigan At Ann Arbor · R01 · FY2011 · DA

Entry and Engagement in Methadone Maintenance Treatment

$726,921
Friends Research Institute, Inc. · R01 · FY2005 · DA

Prescription Opioid Misuse: A Pharmacist-Led Intervention at Point of Service Efficacy Trial

$726,896
Gerald T. Cochran · University Of Utah · R01 · FY2022 · DA

Protective effects of DA antagonists Vs METH induced toxicity in rats

$726,838
Jean Lud Cadet · National Institute On Drug Abuse · ZIA · FY2016 · DA

Pathways to Recovery: Older Substance Users

$726,774
Christy K Scott · Chestnut Health Systems, Inc. · R01 · FY2014 · DA

Development of a Point-of-Care Volumetric Bar-Chart Chip for Drug Quantitation

$726,771
Lidong Qin · Methodist Hospital Research Institute · R01 · FY2014 · DA

Dopaminergic Mechanisms Underlying Human Social Behavior: A Multimodal Approach

$726,762
Ming Hsu · University Of California Berkeley · R01 · FY2019 · MH

Dual Mechanisms of Cognitive Control

$726,753
Todd Braver · Washington University · R37 · FY2015 · MH

Modeling circuit-specific psychiatric deep brain stimulation and its cognitive effects in macaques

$726,687
Benjamin Y Hayden · University Of Minnesota · R01 · FY2020 · MH

Structure Function of CB1 Cannabinoid Receptor

$726,665
Raymond C Stevens · University Of Southern California · R01 · FY2016 · DA

Childhood and Adolescent Predictors of Substance Abuse in Emerging Adulthood

$726,544
Judy A Andrews · Oregon Research Institute · R01 · FY2013 · DA

MEDICATION DEVELOPMENT FOR PROTRACTED ABSTINENCE IN ALCO

$726,516
Scripps Research Institute · R01 · FY2003 · AA

Florida Node of The Drug Abuse Clinical Trials Network

$726,457
Jose Szapocznik · University Of Miami School Of Medicine · U10 · FY2010 · DA

Naltrexone for Opioid Dependent Released HIV+ Criminal Justice Populations

$726,374
Sandra Ann Springer · Yale University · R01 · FY2014 · DA